Theleme Partners LLP

Q4 2021 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Lucy Elwes - Chief Compliance Officer
Location
London, United Kingdom
Holdings as of
31 Dec 2021
Value $
$3.25B
Num holdings
9
Filing time
26 May 2022, 12:11:44
Form type
13F-HR/A-2 - Restatement
Description
All US holdings of this investor are reported in this report. Top holdings included MRNA, WFC, AA, META, and MU.
Previous filing
Q3 2021 - 26 May 2022
Next filing
Q1 2022 - 13 May 2022
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q4 - Restatement compared to 2021 Q3 - Restatement by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Lucy Elwes Chief Compliance Officer London, United Kingdom 26 May 2022

This is an amendment to reflect corrections to Column 7 and Column 8 of the Information Table.

Other Included Managers (2):

Num Name Location File Number
1 Theleme Master Fund Ltd Dublin 028-14311
2 Theleme Special Purpose Fund I LP Dublin 1 028-22495